Gestala Raises $84 Million to Enhance Brain Health Technologies
Gestala, a company specializing in ultrasound brain-computer interfaces (BCI), neuromodulation, and functional ultrasound imaging (fUS), has successfully raised $84 million in its latest funding round. Headquartered in Shanghai, China, Gestala is at the forefront of developing technologies aimed at improving brain health.
Funding Round Details
The funding round, which took place on August 26, 2026, did not disclose a lead investor. However, it saw the participation of several prominent investors, including C Capital, Dalton Venture, Gobi Partners, HSG, Lens Technology, Seas Capital, Sinovation Ventures, and Tsing Song Capital.
Leadership and Vision
Phoenix Peng, the founder and CEO of Gestala, leads the company in its mission to innovate within the field of brain health. Peng's leadership is instrumental in steering the company towards its goals of advancing ultrasound-based technologies for medical applications.
Strategic Use of Funds
While specific plans for the newly raised capital were not detailed, the funding is expected to bolster Gestala's research and development efforts. This could potentially include expanding their technological capabilities and enhancing their product offerings in the realm of brain-computer interfaces and neuroimaging technologies.
Gestala's continued focus on ultrasound technology aims to push the boundaries of brain health solutions, providing new avenues for diagnosis and treatment in neurological conditions.